April 23, 2025 | 09:49
A breakthrough in preclinical data puts CK Life Sciences at the forefront of next-gen immuno-oncology.
April 03, 2025 | 13:51
LBB Specialties, a leader in specialty chemicals and ingredient distribution in North America , is pleased to announce a new partnership with Kerry Group.
March 04, 2025 | 14:55
Known as one of Vietnam’s most notable new-generation trade deals, the EU-Vietnam Free Trade Agreement (EVFTA) marks a significant milestone in the 30-year journey of cooperation and development between both sides. Over five years of implementation, it has left a profound impact on Vietnam’s economy and its pharmaceutical market in particular.
January 20, 2025 | 10:05
Strong growth potential is expected to spur on mergers and acquisitions in Vietnam’s healthcare and pharmaceutical industry in 2025, but a more business-conducive environment is being called for so that the potential is actually reached.
November 26, 2024 | 09:32
The Vietnam Report JSC announced the list of top 10 reputable companies in the pharmacy, medical supply and health care for 2024.
November 13, 2024 | 15:18
With over a decade of pioneering solutions in Vietnam’s pharmaceutical sector, Takeda has been recognised for its contributions to sustainable development.
November 12, 2024 | 07:00
WuXi AppTec, has been ranked #1 in the global Life Sciences Tools & Services sector in the 2024 S&P Global Corporate Sustainability Assessment.
September 27, 2024 | 20:22
To achieve sustainable development in the healthcare and pharmaceutical sectors, Vietnam must adopt the strategy of 'go far, go together' through international cooperation and attracting foreign investment.
September 26, 2024 | 17:21
Health innovation and biotechnology could help Vietnam keep pace with global trends in healthcare.
September 25, 2024 | 17:22
Industry experts gave their views on how to attract foreign investment to the pharmaceutical sector at a VIR panel on September 25.
September 25, 2024 | 11:08
Vietnam healthcare market size is estimated to reach $23.7 billion and grow at an average rate of 7.5 per cent annually from 2023 to 2028. Healthcare expenditure per capita is also projected to increase from $237 to $328 in that time.
August 01, 2024 | 21:54
Leading Indian pharmaceutical corporations have proposed significant investment in Vietnam.
July 31, 2024 | 16:19
While continuing to make positive business results in Vietnam’s pharma market in the first half of 2024, multinationals are seeking an expansion of their rights.
May 21, 2024 | 15:33
The Vietnamese pharmaceutical industry is seeing great advantages.
April 02, 2024 | 08:00
Imexpharm Corporation announced its business results on March 27, for the fiscal year ending December 31, 2023.